Ashvattha Therapeutics
0 followers
‌
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.
Industries
Headquarters
Employees
Links
Org chart
Jeffrey L. Cleland
Chairman, President & CEO
Jeffrey L. Cleland
Collapse
Steve Carlos
VP, Manufacturing
Elizabeth Torrelio
Head, Program Management
Natacha Le Moan
Head, Translational Biology
Debra Nguyen
Sr. Manager, Accounting
Jay Z.
Board Director
Jeannie Skinner
Head of Regulatory Affairs
Jennifer Herber
Associate Director
Mark Feng
Director, Analytical Development
Christine S.
Director, Project Management
Naze Gul Avci, Ph.D.
Senior Scientist
